A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Clinical trial NCT03882970 · COMPLETED
Trial details
- NCT number
- NCT03882970
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-12-11
- Enrollment
- 1444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.